バイオ医薬品向けバイオ分離システムの世界市場

◆英語タイトル:Biopharmaceutical Bioseparation Systems : Global Strategic Business Report
◆商品コード:GIA60150
◆発行会社(調査会社):Global Industry Analysts
◆発行日:2016年1月
◆ページ数:258
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(DRM付き)USD4,500 ⇒換算¥513,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Industry Analysts社の日本における正規販売代理店です。Global Industry Analysts社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、バイオ医薬品向けバイオ分離システムの世界市場について調査・分析し、バイオ医薬品向けバイオ分離システムの世界市場規模、市場動向、市場予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 52 companies including many key and niche players such as –
3M Company
Agilent Technologies, Inc.
Alfa Wassermann Separation Technologies, LLC
Flottweg Separation Technology
GEA Westfalia Separator Group GmbH

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. OUTLOOK
Bioseparation Systems – Invaluable Tools in Biopharmaceutical Manufacturing
US Remains Market Leader; Developing Countries to Drive Market Growth
Chromatography Leads the Pack
Competitive Landscape
Table 1: Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2014): Percentage Breakdown of Revenues for 3M Purification, GE Healthcare Life Sciences, Merck Millipore, Pall Corporation, Sartorius and Others (includes corresponding Graph/Chart)
2. INDUSTRY OVERVIEW
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products – An Overview
Growing Biopharmaceuticals Market Drives Demand for Bioseparation Systems
2014-15: A Launch-Driven Period for Biopharmaceuticals
Recently Approved Biopharmaceuticals: 2013, 2014 & 2015
Biopharmaceutical Industry Transforms Downstream Processing
Growing Market for Monoclonal Antibodies – A Key Review of Current Status and Future Prospects
Approved Monoclonal Antibodies for Therapeutic Use: 1986-2014
An Insight into Bioseparation of mAbs
Growing Biosimilars Market – A Clear Advantage for Bioseparation Technologies
Table 2: Global Biosimilars Market Size Estimates and Forecasts: 2012-2018F (includes corresponding Graph/Chart)
2015: A year of Patent Expiries for Biologics
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
R&D Funding Crucial for Biologics and Bioseparation market
Table 3: Global Biopharmaceutical R&D Expenditure: 2010- 2015E (includes corresponding Graph/Chart)
Huge Biopharmaceutical Pipeline – A Clear Indicator of Future Prospects
Table 4: Biopharmaceutical Products’ Pipeline by Therapeutic Category (2015) (includes corresponding Graph/Chart)
Table 5: No. of Pipeline Biopharmaceuticals for Cancer by Site (2015) (includes corresponding Graph/Chart)
Table 6: No. of Pipeline Biopharmaceuticals for HIV/AIDS Treatment by Type of Therapy (2015) (includes corresponding Graph/Chart)
Insulin Products in Development
Growing Biological Drug Manufacturing Capacity to Drive Growth
3. BIOSEPARATION TECHNOLOGIES – KEY TRENDS
Increasing Need for Further Advances in Downstream Processing Techniques
Process Optimization and Cost Reduction – Key Goals of Innovations in Bioseparation
Single-Use Disposable Technologies Gain Attention
Select Commercial Disposable/Single-Use Technologies by Process Technique
Innovations in Single-use Systems
Changing Paradigm of Primary Recovery in Bioseparation
Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
Chromatography – the Gold Standard Purification Technology
Bioprocess Membrane Technology Offers Significant Benefits over Conventional Technologies
Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
A Comparison of Protein and Synthetic Ligands
Increasing Alternatives to Protein A Column based Capturing
Twin-Column SMB – An Emerging Alternative to Protein A Columns
Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
SMBC – An Old Approach Gaining Significant Attention
A Comparison of Major Advantages and Disadvantages of SMBC
Magnetic Separation as an Alternative to Chromatography – A Review
Reversible Precipitation – A Novel Bioseparation Technology
4. PRODUCT OVERVIEW
Biological Products – An Overview
Classification of Biological Products by Application
Classification of Biological Products by Chemical Nature
Bioseparation – An Overview
Commonly Used Bioseparation Processes by Factors
Bioseparation – A Challenging, Complex and Expensive Process
Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
Classification of Bioseparation Techniques based on Resolution and Throughput
Bioseparation Costs as a Percentage of Processing by Biological Product
Key Bioseparation Techniques
Chromatography
Centrifugation
Membrane Separation
Filtration
Overview of Other Bioseparation Techniques
Adsorption
Extraction
Precipitation
Classification of Bioseparation Techniques based on Physical Form
Particle-Liquid Separation
Particle-Particle Separation
Solute-Solvent Separation
Solute-Solute Separation
Liquid-Liquid Separation
Particle-Solute Separation
RIPP in Bioseparation – The Conventional Scheme for Developing Processes
5. RECENT INDUSTRY ACTIVITY
Merck Acquires Sigma-Aldrich
EMD Millipore Launches Sterilizing-Grade Millipore Express® PHF Hydrophilic Filters
Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind™ Technology
EMD Millipore Unveils Pellicon® Tangential Flow Filtration System
ImmunoReagents and ProteoVec Launch PV-Pure Ig™ Antibody Purification Kits
Pall Acquires Tarpon’s BioSMB Platform
AMSBIO Introduces MagSi-Direct for Bioseparations
EMD Millipore Rolls Out PureFlex™ Plus Disposable Process Container Film
EMD Millipore Rolls Out New Resins for Chromabolt® Chromatography Columns
Thermo Fisher Scientific Launches New Chromatography Resin
Thermo Fisher Scientific to Introduce GlycanPac
Column at Pittcon 2014
Pall Corporation Acquires ATMI’s Life Sciences Business Division
Purolite to Develop Bioseparation Resins for Chromatography
EMD Millipore Unveils Innovative Single-Stage Clarification Clarisolve® Depth Filters
Thermo Fisher Scientific Introduces New 3000 BioRS System
Thermo Fisher Scientific Launches
and
HPLC Columns
EMD Millipore Introduces Smart Flexware® Assemblies Along with Mobius® FlexReady Solution
6. FOCUS ON SELECT PLAYERS
3M Company (US)
3M Purification, Inc. (US)
Agilent Technologies, Inc. (US)
Alfa Wassermann Separation Technologies, LLC (US)
Flottweg Separation Technology (US)
GEA Westfalia Separator Group GmbH (Germany)
GE Healthcare (UK)
KNAUER Wissenschaftliche Geräte GmbH (Germany)
Konik Nanobiotech SL (Spain)
Merck KGaA (Germany)
NuSep Holdings Ltd. (Australia)
Pall Corporation (US)
ProMetic Life Sciences, Inc. (Canada)
Sartorius Stedim Biotech (France)
Spectrum Laboratories, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Tosoh Bioscience, Inc. (Japan)
YMC Europe GmbH (Germany)
7. GLOBAL MARKET PERSPECTIVE
Table 7: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 8: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 9: World 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region – Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 10: World Recent Past, Current & Future Analysis for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 12: World 11-Year Perspective for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region – Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 13: World Recent Past, Current & Future Analysis for Other Biopharmaceutical Bioseparation Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 14: World Historic Review for Other Biopharmaceutical Bioseparation Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 15: World 11-Year Perspective for Other Biopharmaceutical Bioseparation Systems by Geographic Region – Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET
1. THE UNITED STATES
A. Market Analysis
Current & Future Analysis
United States: The Largest Biopharmaceutical Market Globally
Table 16: No. of Biologics Approved by the Center for Biologics Evaluation and Research (CBER): 2003-2013 (includes corresponding Graph/Chart)
Impending Patent Expiries Signal Growth Prospects
Table 17: Leading US Biopharmaceuticals by Revenue (in US$ Billion) and Year of Patent Expiry (includes corresponding Graph/Chart)
Select Trends in Biopharmaceutical Market
Manufacturers Shift Focus to Small Bioreactors
Biosimilar Drug Developers Face Higher Litigation Risks
Strategic Corporate Developments
Key Players
B. Market Analytics
Table 18: US Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: US Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 20: US 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
2. CANADA
A. Market Analysis
Current & Future Analysis
Canada – A Lucrative Biopharmaceutical Industry
Key Player
B. Market Analytics
Table 21: Canadian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 22: Canadian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 23: Canadian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
3. JAPAN
A. Market Analysis
Current & Future Analysis
Key Player
B. Market Analytics
Table 24: Japanese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 25: Japanese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 26: Japanese 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Current & Future Analysis
Select Trends in the European Biopharmaceutical Industry
Funding Challenges Faced by Biopharmaceutical Startups
Healthcare Agencies Looking to Embrace Biosimilars to Cut Healthcare Costs
B. Market Analytics
Table 27: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 28: European Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 29: European 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of European Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 30: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 31: European Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 32: European 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A. Market Analysis
Current & Future Analysis
Key Player
B. Market Analytics
Table 33: French Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34: French Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 35: French 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A. Market Analysis
Current & Future Analysis
Key Players
B. Market Analytics
Table 36: German Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 37: German Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 38: German 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 39: Italian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 40: Italian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 41: Italian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A. Market Analysis
Current & Future Analysis
Strategic Corporate Developments
Key Player
B. Market Analytics
Table 42: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 43: UK Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 44: UK 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
A. Market Analysis
Current & Future Analysis
Key Player
B. Market Analytics
Table 45: Spanish Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 46: Spanish Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 47: Spanish 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
A. Market Analysis
Current & Future Analysis
Russia Sets Eyes on Emerging as a Notable Pharmaceutical Industry
Encouragement for Local Manufacturing to Drive Demand
Challenges – Need for Extensive R&D
B. Market Analytics
Table 48: Russian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 49: Russian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 50: Russian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
Market Analysis
Table 51: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 52: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 53: Rest of Europe 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)


5. ASIA-PACIFIC
A. Market Analysis
Current & Future Analysis
Regional Biopharma Players Gain Strength by Innovation and Partnerships
Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
Availability of Scientific Talent – Major Advantage for India
B. Market Analytics
Table 54: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 55: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 56: Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 57: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 58: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 59: Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
Market Analysis
Table 60: Chinese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 61: Chinese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 62: Chinese 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
5b. INDIA
Market Analysis
Table 63: Indian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 64: Indian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 65: Indian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A. Market Analysis
Current & Future Analysis
Strategic Corporate Development
Key Player
B. Market Analytics
Table 66: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 67: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 68: Rest of Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
6. MIDDLE EAST & AFRICA
Market Analysis
Table 69: Middle East & African Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 70: Middle East & African Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 71: Middle East & African 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
7. LATIN AMERICA
Market Analysis
Table 72: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 73: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 74: Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
Table 75: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 76: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 77: Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
7a. BRAZIL
Market Analysis
Table 78: Brazilian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 79: Brazilian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 80: Brazilian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
7b. REST OF LATIN AMERICA
Market Analysis
Table 81: Rest of Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 82: Rest of Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
Table 83: Rest of Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 52 (including Divisions/Subsidiaries - 60)
The United States (32)
Canada (1)
Japan (5)
Europe (18)
- France (3)
- Germany (9)
- The United Kingdom (1)
- Spain (1)
- Rest of Europe (4)
Asia-Pacific (Excluding Japan) (4)

★調査レポート[バイオ医薬品向けバイオ分離システムの世界市場]販売に関する免責事項
★調査レポート[バイオ医薬品向けバイオ分離システムの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆